Early Detection of Bronchial Lesions Using Lung Imaging Fluorescence Endoscope
Author Information
Author(s): N. IKEDA, H. HONDA, T. KATSUMI, T. OKUNAKA, K. FURUKAWA, T. TSUCHIDA, K. TANAKA, T. ONODA, T. HIRANO, M. SAITO, N. KAWATE, C. KONAKA, H. KATO, Y. EBIHARA
Primary Institution: Tokyo Medical University
Hypothesis
Can fluorescence bronchoscopy using the LIFE system improve the diagnostic rate of bronchial lesions, especially early cancer and dysplastic lesions, compared to conventional bronchoscopy?
Conclusion
Fluorescence bronchoscopy significantly improves the detection of dysplastic lesions compared to conventional bronchoscopy.
Supporting Evidence
- The sensitivity for dysplasia detection was 51% by conventional bronchoscopy and 90% by the LIFE system.
- The positive predictive value for dysplasia and cancer was 64% by conventional bronchoscopy and 73% by the LIFE system.
- Localization of abnormal sputum cytology findings was successful in 57% of cases by conventional bronchoscopy and 71% by the LIFE system.
- Fluorescence bronchoscopy may be an important adjunct to conventional bronchoscopy to improve the localization of subtle lesions.
Takeaway
Doctors used a special camera to find early signs of lung cancer in patients, and it worked much better than the usual method.
Methodology
The study compared the performance of the LIFE system with conventional bronchoscopy in 158 patients, analyzing sensitivity and specificity for detecting dysplasia and cancer.
Limitations
The study may have limitations in distinguishing between carcinoma in situ and dysplasia using the LIFE system.
Participant Demographics
112 men and 46 women with a mean age of 64, 84% were current or former smokers.
Want to read the original?
Access the complete publication on the publisher's website